Seven of nine cleared symptoms and laboratory abnormalities within days to weeks of therapy initiation; one patient showed a clear trend toward improvement.
← all excerpts
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.
1
—
—